Prevalence of parvovirus infection in the Northwestern federal district of Russia
- Authors: Lavrentieva I.N.1, Antipova A.Y.1, Zheleznova N.V.1
-
Affiliations:
- St. Petersburg Pasteur Institute
- Issue: Vol 14, No 6 (2024)
- Pages: 1221-1226
- Section: SHORT COMMUNICATIONS
- URL: https://journals.rcsi.science/2220-7619/article/view/283040
- DOI: https://doi.org/10.15789/2220-7619-POP-17798
- ID: 283040
Cite item
Full Text
Abstract
Here, we analyze the spread of parvovirus B19 infection in the Northwestern Federal District from the years 2018 to 2023. It was shown that cases of infection were recorded in 10 out of 11 territories, excepting the Nenets Autonomous Okrug. Overall, IgM antibodies to parvovirus B19 (B19V) were detected in 295 samples out of 2079 tested (14.1%). The prevalence of parvovirus B19 infection varied over the years of the study: in 2023, an increase in incidence was detected in the Northwestern Federal District, with an indicator of 0.93 per 100 thousand population, which significantly exceeded the long-term average level of 0.43 per 100 thousand population in the district. Children under 14 years of age predominated in the age pattern. The virus circulated most actively in St. Petersburg and the Leningrad region, which is due to the high population density in these territories and the many municipal institutions where long-term close contacts between people take place. The winter-spring seasonality of the infection has been confirmed. An analysis of primary diagnoses in patients with laboratory-confirmed parvovirus infection (2022) showed that the correct clinical diagnosis was not established in any case. The most common clinical diagnostic errors were: “Acute respiratory infection”; “Measles” and “Rubella”; herpes virus infections. In 30% of cases, parvovirus B19 infection was assessed by clinicians as a non-infectious disease. Errors in the initial diagnosis of parvovirus infection can contribute to the spread of infection, including in risk groups. Thus, while examining patients at a dialysis center, laboratory methods revealed latent parvovirus B19 circulation in this risk group confirmed by the detection of B19V DNA and virus-specific IgM antibodies in some samples tested. The seroprevalence established among patients not exceeding 76.9% accounts for an opportunity of infection spread among patients seronegative for parvovirus B19 with worsening of disease course and prognosis. Considering the widespread distribution of parvovirus infection, when identifying infectious diseases and respiratory diseases that occur with unclear exanthema manifestations among people at risk and/or from organized groups, it is advisable to conduct targeted serological monitoring for laboratory markers of parvovirus B19 infection. One of the directions for further qualitative study of parvovirus infection is to solve an issue of its identification and recording in the epidemiological surveillance system.
Full Text
##article.viewOnOriginalSite##About the authors
Irina N. Lavrentieva
St. Petersburg Pasteur Institute
Author for correspondence.
Email: pasteur.lawr@mail.ru
DSc (Medicine), Leading Researcher, Head of the Virology Department
Russian Federation, St. PetersburgA. Yu. Antipova
St. Petersburg Pasteur Institute
Email: pasteur.lawr@mail.ru
PhD (Biology), Researcher, Laboratory of Experimental Virology
Russian Federation, St. PetersburgN. V. Zheleznova
St. Petersburg Pasteur Institute
Email: pasteur.lawr@mail.ru
PhD (Biology), Leading Researcher, Laboratory of Viral Hepatitis
Russian Federation, St. PetersburgReferences
- Антипова А.Ю., Дробышевская В.Г., Хамитова И.В. Случай парвовирусной В19 инфекции и иммунодефицитного состояния у пациента с синдромом Жильбера // Медицинская иммунология. 2021. Т. 23, № 5. С. 1177–1182. [Antipova A.Yu., Drobyshevskaya V.G., Khamitova I.V. Case of parvovirus B19 infection and immunodeficiency in the patient with Gilbert syndrome. Meditsinskaya Immunologiya = Medical Immunology (Russia), 2021, vol. 23, no. 5, pp. 1177–1182. (In Russ.)] doi: 10.15789/1563-0625-COP-2325
- Лаврентьева И.Н., Антипова А.Ю., Бичурина М.А., Хамитова И.В., Никишов О.Н., Кузин А.А. Маркеры парвовирусной инфекции у лиц с экзантемными заболеваниями и в группах риска // Журнал инфектологии. 2019. Т. 11, № 3. С. 110–117. [Lavrentieva I.N., Antipova A.Yu., Bichurina M.A., Khamitova I.V., Nikishov O.N., Kuzin A.A. Parvirus infection markers in persons with exantemic diseases and in risk groups. Zhurnal infektologii = Journal Infectology, 2019, vol. 11, no. 3, pp. 110–117. (In Russ.)] doi: 10.22625/2072-6732-2019-11-3-110-117
- Лаврентьева И.Н., Антипова А.Ю. Парвовирус В19 человека: характеристика возбудителя, распространение, диагностика обусловленной им инфекции // Инфекция и иммунитет. 2013. Т. 3, № 4. С. 311–322. [Lavrentyeva I.N., Antipova A.Yu. Human parvovirus B19: virus characteristics, distribution and diagnostics of parvovirus infection. Infektsiya i immunitet = Russian Journal of Infection and Immunity, 2013, vol. 3, no. 4, pp. 311–322. (In Russ.)] doi: 10.15789/2220-7619-2013-4-311-322
- Лаврентьева И.Н., Антипова А.Ю., Бичурина М.А., Никишов О.Н., Железнова Н.В., Кузин А.А. Выявление случаев парвовирусной инфекции в системе эпидемиологического надзора за экзантемными заболеваниями // Инфекция и иммунитет. 2016. Т. 6, № 3. С. 219–224. [Lavrentyeva I.N., Antipova A.Y., Bichurina M.A., Nikishov O.N., Zheleznova N.V., Kuzin A.A. Detection of cases of parvovirus infection in the system for epidemiological surveillance of exanthematic diseases. Infektsiya i immunitet = Russian Journal of Infection and Immunity, 2016, vol. 6, no. 3, pp. 219–224. (In Russ.)] doi: 10.15789/2220-7619-2016-3-219-224
- Никишов О.Н., Кузин А.А., Антипова А.Ю., Лаврентьева И.Н., Мальцев О.В., Козлов К.В., Антоничев Е.А., Никишов С.Н., Сигидаев А.С. Атипичное течение парвовирусной В19 инфекции при сочетанном инфицировании (клиническое наблюдение) // Журнал инфектологии. 2023. T. 15, № 1. C. 126–133. [Nikishov O.N., Kuzin A.A., Antipova A.Yu., Lavrentieva I.N., Maltsev O.V., Kozlov K.V., Antoniсhev E.A., Nikishov S.N., Sigidaev A.S. Atypical course of parvovirus B19 infection with combined infection (clinical observation). Zhurnal infektologii = Journal Infectology, 2023, vol. 15, no. 1, pp. 126–133. (In Russ.)] doi: 10.22625/2072-6732-2023-15-1-126-
- Никишов О.Н., Кузин А.А., Зобов А.Е., Лаврентьева И.Н., Антипова А.Ю., Останкова Ю.В., Хамитова И.В., Никишов О.Н. Результаты исследования распространенности и активности циркуляции парвовируса B19 (Parvoviridae, Parvovirinae, Erythroparvovirus, Primate erythroparvovirus 1 среди социально значимых категорий населения // Вопросы вирусологии. 2020. Т. 65, № 3. С. 143–149. [Nikishov O.N., Kuzin A.A., Zobov A.E., Lavrentieva I.N., Antipova A.Y., Ostankova Yu.V., Khamitova I.V., Nikishov S.N. Results of a study of parvovirus B19 (Parvoviridae, Parvovirinae, Erythroparvovirus, Primate erythroparvovirus 1) prevalence and circulation activity in socially significant categories of the population. Voprosy virusologii = Problems of Virology, 2020, vol. 65, no. 3, pp. 143–149. (In Russ.)] doi: 10.36233/0507-4088-2020-65-3-143-149
- Слободенюк А.В., Косова А.А., Ан Р.Н. Эпидемиологический анализ: учебное пособие. Екатеринбург: Издательство ГБОУ ВПО УГМУ МЗ РФ, 2015. 36 с. [Slobodenyuk A.V., Kosova A.A., An R.N. Epidemiological analysis: training manual. Ekaterinburg: Publishing house of Ural State Medical University, 2015. 36 p. (In Russ.)]
- Хамитова И.В., Останкова Ю.В., Антипова А.Ю., Семенов А.В., Лаврентьева И.Н. Молекулярно-генетическая характеристика изолятов парвовируса B19, циркулирующих на территории Северо-Западного федерального округа // Журнал микробиологии, эпидемиологии и иммунобиологи. 2018. T. 95, № 6. С. 55–66. [Khamitova I.V., Ostankova Y.V., Antipova A.Y., Semenov A.V., Lavrentieva I.N. Molecular-genetic characteristics of parvovirus B19 isolates circulating in the North-Western Federal district. Zhurnal mikrobiologii, epidemiologii i immunobiologii = Journal of Microbiology, Epidemiology and Immunobiology, 2018, vol. 95, no. 6, pp. 190–193. (In Russ.)] doi: 10.36233/0372-9311-2018-6-55-61
- Чернова Т.М., Дубко М.Ф. Парвовирус В19 как причина кардита в сочетании с миозитом // Медицинский совет. 2018. № 2. С. 190–193. [Chernova Т.M., Dubko M.F. Parvovirus B19 as a cause of carditis in combination with myositis. Meditsinskiy sovet = Medical Council, 2018, no. 2, pp. 190–193. (In Russ.)] doi: 10.21518/2079-701X-2018-2-190-193
- Douvoyiannis M., Litman N., Goldman D.L. Neurologic manifestations associated with parvovirus B19 infection. Clin. Infect. Dis., 2009, vol. 48, no. 12, pp. 1713–1723. doi: 10.1086/599042
- Izquierdo-Blasco J., Allende M.T.S., Grau M.G.C., Gran F., Sáez E.M., Balcells J. Parvovirus B19 myocarditis: looking beyond the heart. Pediatr. Dev. Pathol., 2020, vol. 23, no. 2, pp. 158–162. doi: 10.1177/1093526619865641
- Katz V.L., Chescheir N.C., Bethea M. Hydrops fetalis from B19 parvovirus infection. J. Perinatol., 1990, vol. 10, no. 4, pp. 366–368.
- Kishore J., Kishore D. Fatal missed case of hemophagocytic lymphohistiocytosis co-infected with parvovirus B19 and Epstein–Barr virus in an infant: test hyperferritinaemia early. Indian J. Med. Microbiol., 2014, no. 32, pp. 181–183. doi: 10.4103/0255-0857.129819
- Lavrentyeva I.N., Khamitova I.V., Slita A.V., Levkovski A.E., Diallo A.A., Diallo A.K., Sow T.C., Naydenova E.V., Agafonov D.A., Senichkina A.M. Impact of coinfection of PVB19 on the course and prognosis of malaria caused by Plasmodium falciparum. Russian Journal of Infection and Immunity, 2018, vol. 8, no. 3, pp. 383–387. doi: 10.15789/2220-7619-2018-3-383-387 doi: 10.15789/2220-7619-2018-3-383-387
- Toan N.L., Sy B.T., Song L.H., Luong H.V., Binh N.T., Binh V.Q., Kandolf R., Velavan T.P., Kremsner P.G., Bock C.T. Co-infection of human parvovirus B19 with Plasmodium falciparum contributes to malaria disease severity in Gabonese patients. BMC Infect. Dis., 2013, vol. 13: 375. doi: 10.1186/1471-2334-13-375
Supplementary files
